Addison Carnahan, PA
Physician Assistant · Toledo, OHNPI 1285305706
Payments from drug & device makers
Across 307 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Optinose US, Inc.$1K
- AbbVie$907
- Sanofi$840
- GSK$713
- Pfizer$594
- Regeneron Healthcare Solutions, Inc.$503
- plus $2K from 15 others
What the payments were for
- Food & beverage$6,22899%
- Education$341%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Optinose US, Inc. | 42 | $1,012 |
| AbbVie | 102 | $907 |
| Sanofi | 28 | $840 |
| GSK | 27 | $713 |
| Pfizer | 33 | $594 |
| Regeneron Healthcare Solutions, Inc. | 34 | $503 |
| Aerin Medical Inc. | 4 | $464 |
| Phathom Pharmaceuticals, Inc. | 9 | $267 |
| Vertex | 4 | $170 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $154 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| Acclarent, Inc | 2 | $122 |
| Cochlear Americas | 1 | $109 |
| AstraZeneca | 4 | $77 |
| Medtronic | 1 | $55 |
| Amgen | 2 | $50 |
| Phadia US Inc. | 2 | $39 |
| Alk-abello, Inc | 1 | $20 |
| Kaleo, Inc. | 1 | $15 |
| Sage Therapeutics, LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$324
- RHINAER STYLUS$324
- NUCALA$250
- DUPIXENT$247
- Xhance$244
- UBRELVY$231
- QULIPTA$125
- Symbravo$125
- ZAVZPRET$121
- JOURNAVX$119
- Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$109
- Baha$109
- OSIA OSI300 IMPLANT$109
How this compares
$6,262 in reported general payments places this provider in the 95th percentile of 4,098 physician assistant providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 111 | $3,749 |
| Famotidine | 357 | $2,933 |
| Azelastine Hcl | 106 | $2,656 |
| Ofloxacin | 59 | $2,459 |
| Fluticasone Propionate | 214 | $2,388 |
| Omeprazole | 105 | $1,333 |
| Mometasone Furoate | 12 | $1,164 |
| Esomeprazole Magnesium | 13 | $1,066 |
| Montelukast Sodium | 53 | $535 |
| Prednisolone Acetate | 16 | $473 |
| Pantoprazole Sodium | 28 | $459 |
| Sulfacetamide Sodium | 13 | $377 |
| Doxycycline Hyclate | 34 | $372 |
| Lidocaine Hcl ViscousLidocaine Hcl | 12 | $238 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 21 | $183 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Toledo
- Alison FleigToledo$48K
- Ashley SheskeyToledo$20K
- Jessica PalickiToledo$19K
- Steven WurzelbacherCincinnati$309K
- Emily AnkromDayton$192K
- Amanda MaggartWorthington$164K
- Megan SevillaMayfield Heights$132K
- Erin StrculaBelpre$106K
- Natalie WalkupSylvania$105K
- Sarah LaubNew Albany$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.